SCHEMBL30037043

SCHEMBL30037043

COC(=O)c1ncc(C)c(-c2ccc(C#N)cc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.43
▸ EGLN2 Q96KS0 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ EGLN1 Q9GZT9 1/20 0.40
▸ AR P10275 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CTSA P10619 1/20 0.38
▸ XDH P47989 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SCN2A Q99250 2/20 0.37
▸ SCN10A Q9Y5Y9 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ VNN1 O95497 1/20 0.37
▸ TRPA1 O75762 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25552027 1.00 PDK1 (0.43) PDK1EGLN2ALDH1A1CYP11B1CYP11B2
SCHEMBL25552017 0.85 PDK1 (0.45) PDK1EGLN2EGLN1SCN2ASCN10A
SCHEMBL30036156 0.85 PDK1 (0.45) PDK1EGLN2EGLN1SCN2ASCN10A
SCHEMBL25559966 0.82 NPC1 (0.48) ALDH1A1LMNASMN1; SMN2
SCHEMBL24572726 0.82 ALDH1A1 (0.61) ALDH1A1MAPK1MEN1KMT2ALMNA
SCHEMBL25560272 0.82 PDK1 (0.43) PDK1ALDH1A1CYP11B2EGLN1SCN2A
SCHEMBL30037120 0.81 CTSA (0.44) EGLN2CYP11B1CYP11B2EGLN1CTSA
SCHEMBL25552037 0.81 CTSA (0.44) EGLN2CYP11B1CYP11B2EGLN1CTSA
SCHEMBL25551988 0.76 ALDH1A1 (0.40) ALDH1A1CYP11B1CYP11B2MAPK1CTSA
SCHEMBL30036994 0.76 PDK1 (0.53) PDK1EGLN2ALDH1A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115515940-A Inhibitors of receptor interacting protein kinase I for the treatment of disease 德州大学系统董事会 2022-12-23 — — CN disclosed
Send feedback